Contact
Please use this form to send email to PR contact of this press release:
Apellis and Sobi Announce First Patient Dosed in Potentially Registrational ALS Study of Pegcetacoplan
TO:
Please use this form to send email to PR contact of this press release:
Apellis and Sobi Announce First Patient Dosed in Potentially Registrational ALS Study of Pegcetacoplan
TO: